Paolo Boffetta, MD Email Paolo Boffetta
-
- Positions
- PROFESSOR | Medicine, Hematology and Medical Oncology
- PROFESSOR | Oncological Sciences
- PROFESSOR | Environmental Medicine & Public Health
-
- Language
- English
Dr. Boffetta joined the Icahn School of Medicine at Mount Sinai in 2010. He is Associate Director for Global Oncology of The Tisch Cancer Institute.
Dr. Boffetta's previous employments include Columbia University (New York, NY), the American Cancer Society (New York, NY), the American Cancer Society (New York, NY), the International Agency for Research on Cancer (Lyon, France), and the German Cancer Research Center (Heidelberg, Germany).
Dr. Boffetta holds a part-time Professorship at the University of Bologna, Italy, and is Adjunct Professor at the Harvard School of Public Health (Boston, MA), Vanderbilt University (Nashville, TN), University of South Carolina (Columbia, SC) and the Catholic University of Rome (Italy). He is also Affiliate Member of the R. Samuel McLaughlin Centre for Population Health Risk Assessment, University of Ottawa (Ottawa, Canada), and Senior Fellow of the Hellenic Health Foundation (Athens, Greece).
Dr. Boffetta is the author of over 1,300 peer-reviewed publications, mainly in the field of epidemiology of cancer and other chronic diseases. He has edited 15 books and authored over 80 book chapters. He is associate editor of Annals of Oncology, Cancer Medicine, European Journal of Clinical Investigation, and editor of Frontiers in Cancer Epidemiology, and is a member for more than 10 editorial boards of scientific journals. He is the founding member of several international cancer epidemiology consortia and networks.
Major Research Interests:
- Molecular and genetic epidemiology
- Cancer Epidemiology
- Cardiovascular and diabetes epidemiology
- Cancer prevention
- Epidemiologic methods
{C}
Read a press release on Dr. Boffetta's study of the relationship between high consumption of fruits and vegetables and risk of cancer.
Watch a video from BMJ.com on tea drinking habits and oesophageal cancer in Iran.
Multi-Disciplinary Training Area
Cancer Biology [CAB]
Education
Internship, University Hospital Turin
MD, University of Turin
MPH, Columbia University
Language
English
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Boffetta during 2019 and/or 2020. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting:
- Chemrisk
- Edison SpA
- Eni S.p.A.
- Exponent
- Monsanto Company
- Ramboll Environ
- Vinmec Health System
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.